1MERIT-HF study Group.Effect of metoprolol CR/XL in chronic heart failure:Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)[J].Lancet,1999,353:2001.
2Eichhorn E J,Bristow M R.The Carvedilol Prospective Randomized Cumulative survival (COPERNICUS) trial[J].Curr Control Trial Cardiovase Med,2001,2:20.
2Cleland JG, Clark A. Has the survival of the heart failure population changed? Lessons from trials. Am J Cardiol, 1999,83:112D-119D.
3Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J, 1997,133:703-712.
4Gary R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA, 1995,273:1450-1456.
5Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet, 1998,352:19-28.
6Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure: a request for more accurate classification. Eur Heart J, 1996,17:1390-1403.
7Pierpont GL, Cohn JN, Franciosa JA. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest, 1978,73:8-13.
8Jugdutt BI, Khan MI. Effect of prolonged nitrate therapy on left ventricular remodeling after canine myocardial infarction. Circulation, 1994,89:2297-2307.
9Packer M, O′Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in servere chronic heart failure. N Engl J Med, 1996,335:1107-1114.
10Cohn JN, Ziesche S, Smith R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-Heft III. Circulation, 1997,96:856-863.
